Humana Inc. (HUM) Upgraded to Outperform at Raymond James

Market Context

Humana Inc. operates in the Healthcare sector. The stock currently trades at $425.26 with a market capitalization of $32.0B. The stock has gained 66.6% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Raymond James's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Humana Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 12, 2026	Raymond James	Outperform	N/A
Oct 09, 2026	Barclays	Overweight	N/A
Oct 09, 2026	Oppenheimer	Outperform	N/A
Oct 09, 2026	Baird	Outperform	N/A
Oct 07, 2026	Cantor Fitzgerald	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View HUM Stock Page